Skip to content
Open access · OA via Europe PMC

Cardiac fibrosis: mechanistic insights and translational advances.

Xie HY, Zheng XT, Wang XH, Yang JY, Liu YX, Zhao Y, Tang HF, Hu HJ.

Molecular biomedicine · 2026

Abstract

Cardiac fibrosis is a critical pathological process driving the progression of heart failure, characterized by excessive extracellular matrix deposition, collagen network remodeling, and expansion of the myocardial interstitium. While fibrosis may reflect a reparative response to tissue injury, it can also signify a maladaptive remodeling process that progressively impairs cardiac structure and function. Cardiac fibroblasts and myofibroblasts serve as the principal effector cells responsible for matrix accumulation, whereas cardiomyocytes and immune cells contribute to fibrotic expansion through inflammatory signaling, paracrine communication, and microenvironmental regulation. Transforming growth factor-β, the renin-angiotensin-aldosterone system, inflammatory cytokines, mechanical stress, and metabolic disturbances collectively orchestrate a profibrotic signaling network. By regulating extracellular matrix synthesis, degradation, and crosslinking, these pathways promote myocardial stiffening and functional decompensation. In this review, we discuss the histopathological patterns of cardiac fibrosis across various pathological contexts, the major cellular contributors, and the core molecular mechanisms involved, while summarizing current advances in diagnostic evaluation and translational therapeutic strategies. We further discuss the context-dependent role of sirtuin 3 (SIRT3), a mitochondrial nicotinamide adenine dinucleotide (NAD⁺)-dependent deacetylase, in linking mitochondrial homeostasis, oxidative stress, metabolic adaptation, and profibrotic signaling. More precise antifibrotic strategies require better definition of fibroblast states, fibrosis activity, and disease-specific remodeling patterns.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
Europe PMC
DOI
10.1186/s43556-026-00587-1
Canonical
link ↗
Fetched
2026-10-11 MST

Cite this

APA
HY, X., XT, Z., XH, W., JY, Y., YX, L., Y, Z., HF, T., &amp; HJ., H. (2026). Cardiac fibrosis: mechanistic insights and translational advances. <em>Molecular biomedicine</em>. https://doi.org/10.1186/s43556-026-00587-1
Vancouver
HY X, XT Z, XH W, JY Y, YX L, Y Z, et al. Cardiac fibrosis: mechanistic insights and translational advances. Molecular biomedicine. 2026. doi:10.1186/s43556-026-00587-1.
BibTeX
@article{xie2026Cardia, title = {Cardiac fibrosis: mechanistic insights and translational advances.}, author = {Xie HY and Zheng XT and Wang XH and Yang JY and Liu YX and Zhao Y and Tang HF and Hu HJ.}, journal = {Molecular biomedicine}, year = {2026}, doi = {10.1186/s43556-026-00587-1}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings